EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical efficacy and prognostic factors of CT-guided radioactive iodine-125 seed implantation for the treatment of superficial soft tissue metastasis: a 12-year retrospective analysis

Weiguang Qiang, Hongbing Shi, Bai Sun, Hao Wang, Chao Wang, Ye Yuan, Wenwei Hu

Radiation Oncology · 2024

DOI: 10.1186/s13014-024-02475-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Oncology, 2024. Verfasst von Weiguang Qiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, People's Republic of China. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Soft Tissue Neoplasms, Tomography, X-Ray Computed, Brachytherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Superficial soft tissue metastasis (S-STM) of malignant tumors is uncommon and often brings great pain to patients. However, current treatment options are limited. The purpose of this study was to explore the clinical efficacy and prognostic factors of CT-guided radioactive iodine-125 ( 125 I) seed implantation (RISI) for the treatment of S-STM.

Methods

We retrospectively evaluated 132 patients with S-STM who received RISI between June 2010 and July 2022. Local tumor progression-free survival (ltPFS), tumor response, pain control and complication were analyzed. The independent factors affecting ltPFS were screened out using a layered Cox proportional hazards model.

Results

The median follow-up time was 8.3 months (interquartile range [IQR], 4.5–15.3 months). The objective response rate (ORR) was 81.8%. The median ltPFS was 9.1 (95% CI: 6.6, 11.6) months. The Cox proportional hazard regression model revealed that the independent factors influencing ltPFS included KPS score, primary tumor, metastases, boundary, density and postoperative D90 (All P < 0.05). After RISI, the rate of pain relief was 92.3%. 66 (84.6%) patients reported pain marked relief, and 6 (7.7%) experienced pain moderate relief. No severe adverse events associated with RISI were observed during follow-up.

Conclusions

CT-guided RISI was associated with high local control and pain relief without severe adverse events and should be considered as a reliable palliative treatment modality for S-STM.

Trial registration

Trial registration Retrospectively registered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesSoft Tissue NeoplasmsTomography, X-Ray ComputedBrachytherapyHumansRetrospective StudiesMaleFemaleMiddle AgedPrognosisAgedAdultRadiotherapy, Image-Guided

Stichwörter der Autor:innen

Iodine-125 brachytherapyPrognostic factorRadioactive iodine-125 seed implantationSuperficial soft tissue metastases

Substanzen

Iodine RadioisotopesIodine-125

Autor:innen und Institutionen

  • Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, People's Republic of China.
  • Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, People's Republic of China. szdxfsdsyy@163.com.

Zitieren

APA

Qiang, W., Shi, H., Sun, B., Wang, H., Wang, C., Yuan, Y., & Hu, W. (2024). Clinical efficacy and prognostic factors of CT-guided radioactive iodine-125 seed implantation for the treatment of superficial soft tissue metastasis: a 12-year retrospective analysis. Radiation Oncology. https://doi.org/10.1186/s13014-024-02475-w

Vancouver

Qiang W, Shi H, Sun B, Wang H, Wang C, Yuan Y, et al. Clinical efficacy and prognostic factors of CT-guided radioactive iodine-125 seed implantation for the treatment of superficial soft tissue metastasis: a 12-year retrospective analysis. Radiation Oncology. 2024. doi:10.1186/s13014-024-02475-w

BibTeX
@article{Qiang2024,
  author = {Qiang, Weiguang and Shi, Hongbing and Sun, Bai and Wang, Hao and Wang, Chao and Yuan, Ye and Hu, Wenwei},
  title = {Clinical efficacy and prognostic factors of CT-guided radioactive iodine-125 seed implantation for the treatment of superficial soft tissue metastasis: a 12-year retrospective analysis},
  journal = {Radiation Oncology},
  year = {2024},
  doi = {10.1186/s13014-024-02475-w}
}
Kostenlos starten →